China approves J&J psoriasis pill Icotyde, says drugmaker
TimesLive | 27.08.2026 20:36
China’s drug regulator has approved Johnson & Johnson’s oral pill for psoriasis, the company said on Thursday, intensifying competition in the world’s second-largest pharmaceutical market with rivals including Bristol Myers Squibb and AbbVie.
